Robert W. Azelby

Non Executive / Member
Login/ Register  to follow report
Company:

About

  • President and Chief Executive Officer of Eliem Therapeutics Inc., a biotechnology company focused on neuronal excitability disorders, from 2020 until 2023
  • President and Chief Executive Officer of Alder BioPharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on prevention of chronic migraines, from 2018 until company was acquired by Lundbeck in 2019
  • Executive Vice President and Chief Commercial Officer of Juno Therapeutics Inc., a biopharmaceutical company, from 2015 until the company was acquired by Celgene in 2018
  • Held various senior roles at Amgen, a multinational biopharmaceutical company, from 2000 until 2015
  • Other current public company directorships:
    • ADC Therapeutics SA, a commercial-stage biotechnology company since 2023
    • Autolus Therapeutics plc, a CAR T cell therapy company, since January 2024
  • Prior public company directorships within the last five years:
    • Chinook Therapeutics Inc., a clinical-stage biopharmaceutical company, from 2023 until the company was acquired later in 2023
    • Eliem Therapeutics Inc., a biotechnology company, from 2020 until 2023
    • Clovis Oncology Inc., a pharmaceutical company, from 2018 until 2022
    • Immunomedics, a biotechnology company, from 2020 until the company was acquired later in 2020
    • Alder BioPharmaceuticals Inc., a clinical-stage biopharmaceutical company, from 2018 until the company was acquired in 2019

 

Personal Details

Title: Mr
Surname: Azelby
DoB: 01/01/2025
Age: 1 years
M/F: Male
Nationality: American
Country of Birth: United States of America
Language: English
Qualification: BA, Economics and Religious Studies, MBA
Industry:

 

Qualifications & Experience

 

Industry Experience +5yrs:
Industry Qualification +5yrs?:
Finance experience +5yrs?:
Finance Qualification +5yrs:
Legal experience +5yrs?:
Delinquent director?:
Other Experiences?:
Collapsed company director?:

 

Other directorships (state)

(only entities turnover at least $5m p/a)

CompanyCommitteePositionDate Appointed
BoardOther Non-Executive01/06/2023
BoardOther Non-Executive01/01/2024

 

Working history

 

Committee/s

CompanyCommitteeRoleAppointment DateResignation Date
Cardinal HealthBoardMember01/03/2024
Cardinal HealthRisk & ComplianceMember01/03/2024

 

Independence Questions

Any family members working for the company?:
Are you doing business with the company?:
Do you hold shares in the company for more than 0.10%? (directly or by representation):
Is your Director annual fee more than 5% of your total income from all sources?:
Are you more than 10 years as a director?:
Are you an executive chairperson?:
InsidEntity has assumed that responses to the Independent Questions are NO as the company has not populated the information. The result will present the Director as Independent.
Download PDF